异基因骨髓移植在无细胞减灭预处理下挽救重型β地中海贫血小鼠
研究建立了一种人源化小鼠重型β地中海贫血(Cooley贫血)模型,在无细胞减灭预处理条件下单次静脉注射异基因骨髓,实现稳定的混合造血嵌合,移植后5个月供体细胞约占循环红细胞的90%,小鼠摆脱输血依赖且无生长迟缓或移植物抗宿主病。
要点
- 无细胞减灭预处理下异基因骨髓移植可挽救Cooley贫血人源化小鼠免于致死性贫血。
- 移植后5个月供体细胞约占循环红细胞90%、造血干祖细胞至多15%。
- 移植小鼠摆脱输血依赖,血液学指标明显改善,无生长迟缓或移植物抗宿主病,且有生育能力。
核心结论
- 在无毒性细胞减灭预处理条件下,异基因骨髓移植可使人源化Cooley贫血小鼠获得稳定混合造血嵌合并免于致死性贫血。
研究设计与样本
- 研究采用人源化小鼠Cooley贫血(重型β地中海贫血)模型,行异基因骨髓移植,未进行细胞减灭预处理。
主要发现
- 单次静脉出生后注射异基因骨髓可导致稳定的混合造血嵌合。
- 移植后5个月,供体细胞约占循环红细胞的90%,占造血干祖细胞至多15%。
- 移植小鼠摆脱输血依赖,血液学指标明显改善,无生长迟缓或移植物抗宿主病征象,且有生育能力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
β-thalassemia is a group of inherited blood disorders that result in defects in β-globin chain production. Cooley anemia (CA), or β-thalassemia major, is the most severe form of the disease and occurs when an individual has mutations in both copies of the adult β-globin gene. Patients with CA fail to make adult hemoglobin, exhibit ineffective erythropoiesis, experience severe anemia, and are transfusion dependent for life. Currently, allogeneic bone marrow transplantation (BMT) is the only cure; however, few patients have suitable donors for this procedure, which has significant morbidity and mortality. In this study, a novel humanized murine model of CA is rescued from lethal anemia by allogeneic BMT in the absence of cytoreductive conditioning. A single intravenous postnatal injection of allogeneic bone marrow results in stable, mixed hematopoietic chimerism. Five months after transplantation, donor cells accounted for approximately 90% of circulating erythrocytes and up to 15% of hematopoietic stem and progenitor cells. Transplanted mice are transfusion independent, have marked improvement of hematological indices, exhibit no growth retardation or signs of graft-versus-host disease, and are fertile. This study describes a method for the consistent engraftment of allogeneic donor hematopoietic cells that rescues a humanized mouse model of CA from lethal anemia, all in the absence of toxic cytoreductive conditioning.
引用
- Huo Y, Lockhart JR, Liu S, et al. Allogeneic bone marrow transplant in the absence of cytoreductive conditioning rescues mice with β-thalassemia major. Blood Adv. 2017. PMID: 29296892. doi:10.1182/bloodadvances.2017009449
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。